Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robbie Murray

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Optics Express|October 14, 2022
Two-photon interference LiDAR imagingRobbie Murray, Ashley Lyons
BMJ Open|October 21, 2022
Experience and response to a randomised controlled trial of extended-release injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone for opioid use disorder: protocol for a mixed-methods evaluationNatalie Lowry, Fiona Cowden, Edward Day, et al.
Addiction (Abingdon, England)|June 20, 2025
Extended-release buprenorphine treatment for opioid use disorder: A mixed-methods study of response and experienceNatalie Lowry, Andrew McKechnie, Edward Day, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Optics Express|October 14, 2022
Two-photon interference LiDAR imagingRobbie Murray, Ashley Lyons
BMJ Open|October 21, 2022
Experience and response to a randomised controlled trial of extended-release injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone for opioid use disorder: protocol for a mixed-methods evaluationNatalie Lowry, Fiona Cowden, Edward Day, et al.
Addiction (Abingdon, England)|June 20, 2025
Extended-release buprenorphine treatment for opioid use disorder: A mixed-methods study of response and experienceNatalie Lowry, Andrew McKechnie, Edward Day, et al.
Pageof 1